|
| 38048050 | Aneuploidy Landscape in Precursors of Ovarian Cancer. | Clin Cancer Res | 2024 |
| 36596784 | The rapid and highly parallel identification of antibodies with defined biological activities by SLISY. | Nat Commun | 2023 |
| 37604828 | Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen. | | 2023 |
| 37725979 | Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer. | Cell Rep Med | 2023 |
| 37716353 | The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring. | Cell Rep Med | 2023 |
| 37565753 | The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer. | Cancer Discov | 2023 |
| 37552989 | Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid. | Cell Rep Med | 2023 |
| 37958547 | The Arising Role of Extracellular Vesicles in Cholangiocarcinoma: A Rundown of the Current Knowledge Regarding Diagnostic and Therapeutic Approaches. | | 2023 |
| 36833401 | Exploiting Autophagy-Dependent Neoantigen Presentation in Tumor Microenvironment. | | 2023 |
| 37014860 | Detection of rare mutations, copy number alterations, and methylation in the same template DNA molecules. | Proc Natl Acad Sci U S A | 2023 |
| 37108330 | An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches. | | 2023 |
| 36539618 | Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. | Nat Genet | 2023 |
| 36782065 | Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. | Nat Genet | 2023 |
| 35178604 | Correction to: Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology. | Virchows Archiv | 2022 |
| 35657320 | Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer. | New England Journal of Medicine | 2022 |
| 36292753 | The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches. | Genes | 2022 |
| 35692635 | An isogenic cell line panel for sequence-based screening of targeted anticancer drugs. | iScience | 2022 |
| 35295598 | Inpatient Administration of Alpha-1-Adrenergic Receptor Blocking Agents Reduces Mortality in Male COVID-19 Patients. | Front Med (Lausanne) | 2022 |
| 34737207 | Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with <i>Fusobacterium nucleatum</i> and Its Subspecies <i>animalis</i>. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35244537 | Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma. | Elife | 2022 |
| 35133659 | Multicancer early detection test: Preclinical, translational, and clinical evidence-generation plan and provocative questions. | Cancer | 2022 |
| 35122030 | Author Correction: Targeting public neoantigens for cancer immunotherapy. | Nature Cancer | 2021 |
| 33493502 | Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients With Barrett's Esophagus. | Gastroenterology | 2021 |
| 34114951 | Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection. | Elife | 2021 |
| 33731480 | Targeting loss of heterozygosity for cancer-specific immunotherapy. | Proceedings of the National Academy of Sciences of the United States of America | 2021 |
| 33941929 | Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands. | Nature Biotechnology | 2021 |
| 33939694 | Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study. | PLoS Medicine | 2021 |
| 33649188 | TCR β chain-directed bispecific antibodies for the treatment of T cell cancers. | Sci Transl Med | 2021 |
| 33649166 | Targeting a neoantigen derived from a common mutation. | Science | 2021 |
| 33649101 | Bispecific antibodies targeting mutant neoantigens. | Science immunology | 2021 |
| 32984952 | Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies. | International Journal of Cancer | 2021 |
| 33405231 | Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma. | Cancer | 2021 |
| 34676374 | Targeting public neoantigens for cancer immunotherapy. | Nature Cancer | 2021 |
| 34380662 | Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers. | Journal for ImmunoTherapy of Cancer | 2021 |
| 34489470 | Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens. | Nature Communications | 2021 |
| 31482302 | Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology. | Virchows Archiv | 2020 |
| 32075918 | Assessing aneuploidy with repetitive element sequencing. | Proc Natl Acad Sci U S A | 2020 |
| 32352407 | Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists. | J Clin Invest | 2020 |
| 32345712 | Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. | Science | 2020 |
| 31605229 | Pathophysiology of ctDNA Release into the Circulation and Its Characteristics: What Is Important for Clinical Applications. | Recent Results in Cancer Research | 2020 |
| 33033144 | Tumor DNA as a Cancer Biomarker through the Lens of Colorectal Neoplasia. | Cancer Epidemiology Biomarkers and Prevention | 2020 |
| 32686686 | Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival. | Nat Commun | 2020 |
| 31462507 | Applications of liquid biopsies for cancer. | Sci Transl Med | 2019 |
| 31690625 | An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation. | Journal of Biological Chemistry | 2019 |
| 31621801 | Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer. | JAMA Oncology | 2019 |
| 30447301 | Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations. | Human Pathology | 2019 |
| 30628066 | The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations. | International Journal of Cancer | 2019 |
| 29420226 | Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study. | Gut | 2019 |
| 31527070 | Direct Detection and Quantification of Neoantigens. | Cancer Immunology Research | 2019 |
| 31028363 | Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma. | Modern Pathology | 2019 |